XTACY Therapeutics Announces Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2023) - Xtacy Therapeutics Corp. (CSE: XTCY) (FSE: TT5) (OTCQB: GWSFF) (formerly Global Wellness Strategies Inc.) ("the Company") announces that it has agreed to settle an aggregate of CA$118,075 in debt through the issuance of common shares.The Company has agreed with certain of its creditors to issue an aggregate of 2,361,500 common shares (the "Settlement Shares") to such creditors in exchange for outstanding accounts payable (the...
2023-10-05 4:05 PM EDT
Global Wellness Pharma Subsidiary Supports Cancer Therapeutic Company AVM Biotechnology
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: GWSFF) ("Global Wellness" or the "Company") pharma subsidiary is excited to work with BioMed360 a GWS medical advisor.GWS pharma subsidiary is focused on providing companies with financial, operational, and management assistance during their clinical trials phase. GWS announces that BioMed360 Solutions Corp signed a letter of intent for the 100% acquisition of AVM...
2022-12-05 8:45 AM EST
Global Wellness Strategies Forms Pharma Subsidiary Focused on Clinical Trials
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: GWSFF) ("Global" or the "Company") a prospect generator that provides high growth companies with financial, operational, and management assistance focused in health and wellness announces the formation of a wholly owned pharma subsidiary focused on clinical trials."Real strategic capital market partnerships are essential to assist our clients in their progression...
2022-11-17 8:30 AM EST
Global Wellness Corporate Quarter Highlights
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") provides quarter corporate highlights.The Company quarter corporate highlights included announcing:May 12th that Global Wellness' Shanti Therapeutics was preparing for their first clinical trial with iNGENü a subsidiary of Australian leader Cannvalate. Shanti' s product suite of MDMA could be the global market winner finding a...
2022-06-27 4:40 PM EDT
Global Wellness Readies for First Clinical Trial
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (OTCQB: GWSFF) (FSE: O3X) ("Global" or the "Company") announces Shanti Therapeutics MDMA Clinical Trial Update.Shanti's product suite of MDMA could be the global market winner finding a solution to the chronic puzzle of pain. iNGENü, a subsidiary of Australian leader Cannvalate, is engaged as the CRO (clinical research organization) by the Company to conduct clinical trials for Shanti...
2022-05-12 8:30 AM EDT
Global Wellness Strategies Closes First Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") is pleased to announce the first tranche closing of its non-brokered private placement (the "Offering") for gross proceeds of $588,500.The securities sold pursuant to the Offering consist of 2,977,779 units of the Issuer ("Units") at a price of CAD$0.18 per unit. Each Unit consists of one common share and one common share...
2022-02-22 7:18 PM EST
Global Wellness Strategies Signs MDMA Supply Agreement with PharmAla Biotech
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") and their Contract Research Organization ("CRO") iNGENü (a fully owned subsidiary of Cannvalate Pty Ltd) sign supply agreement with Canada-based PharmAla Biotech (CSE: MDMA) to supply GMP MDMA for the Shanti Therapeutics upcoming clinical trial.Global Wellness' Shanti Therapeutics is a first-in-class biotech utilizing the...
2022-02-10 9:36 AM EST
Global Wellness' Shanti Therapeutics Submits Human Research Ethics Committee (HREC) Application
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Global Wellness Strategies Inc. (CSE: GWS) (OTCQB: GWSFF) (FSE: O3X) ("Global" or the "Company") and Shanti Therapeutics have submitted their Human Research Ethics Committee (HREC) Application for their first-in-man trials using MDMA for its anti-nociceptive effects. The Company updates on study progress, clinical trials and submission of clinical trial paperwork for the HREC committee.Shanti Therapeutics has submitted an...
2021-11-29 8:45 AM EST
Global Wellness' Shanti Therapeutics Files MDMA Methods Patent
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2021) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: PNNRF) ("Global" or the "Company") updates on MDMA provisional patent applications.Shanti Therapeutics has a filed provisional patent application for the treatment of pain with MDMA. Global Wellness has acquired 100% of the share capital in Shanti Therapeutics and all its constituent intellectual property. Upon completion of the initial clinical trial, the...
2021-11-09 9:43 AM EST
Global Wellness' Meris Kott Speaks at Debut Lift&Co Psychedelics Business Summit
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2021) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: PNNRF) ("Global" or the "Company") is proud to announce the Company CEO Meris Kott will be speaking at the first ever Lift&Co Psychedelic Business Summit which is part of the famous Lift&Co. Expo, Canada's no. 1 cannabis conference and trade show, that is returning to the Metro Toronto Convention Centre, November 18-21, 2021.Company CEO Meris Kott will be moderating...
2021-11-05 9:57 AM EDT
Global Wellness Strategies Shanti Therapeutics Updates and Symbol Change to GWS
Vancouver, British Columbia--(Newsfile Corp. - October 4, 2021) - Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) ("Global" or the "Company") changes symbol to GWS and introduces Dr. Sud Agarwal BSc, MB ChB, FANZCA, the Chairman of Cannvalate Pty Ltd. and Shanti Therapeutics. His experience and expertise in the psychedelic industry will contribute significantly to our efforts in the space moving forward.GWS Symbol Change:Global Wellness...
2021-10-04 8:30 AM EDT
Global Wellness Signs Definitive Agreement with Cannvalate Australia
Vancouver, British Columbia--(Newsfile Corp. - August 9, 2021) - Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) ("Global" or the "Company") is pleased to announce the signing of a definitive agreement on August 6th 2021 memorializing the Global Wellness Strategies, Inc. binding letter of intent signed on July 12th 2021 to purchase certain assets of Cannvalate Pty Ltd. ("CV") based in Australia and to acquire 100% of their wholly owned...
2021-08-09 8:30 AM EDT
Global Wellness Strategies and Cannvalate AU Sign Revolutionary Psychedelic Deal
Vancouver, British Columbia--(Newsfile Corp. - July 19, 2021) - Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) ("Global" or the "Company") is pleased to announce it has signed a binding letter of intent ("BLOI") on July 12, 2021 with Cannvalate Pty Ltd ("CVL") based in Australia to acquire 100% of their wholly owned subsidiary, Shanti Therapeutics Pty Ltd, and all its assets focused on psychedelic MDMA-based drug development. This...
2021-07-19 8:30 AM EDT
Global Wellness Strategies Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) ("GWS" or the "Company") is pleased to provide the following corporate update highlights on two portfolio clients KaleidoMyco LLC and Biominerales Pharma Corp. and announces the signing of the one-stop digital marketing team of North Equities Corp."With the talent, skills and resources we have at Global Wellness, we are well...
2021-06-15 8:45 AM EDT
Global Wellness Strategies and KaleidoMyco Introduce One-Shot Drink Combining Functional Mushrooms with Hemp Extract
Vancouver, British Columbia--(Newsfile Corp. - April 26, 2021) - Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRD) ("GWS" or the "Company") (formerly Redfund Capital Corp.) and KaleidoMyco, one of the first companies combining hemp extract and adaptogens, introduces its flavored antioxidant one-shot beverage combining functional mushrooms with hemp extract.KaleidoMyco is combining 50 milligrams of hemp extract with functional mushrooms to launch a new one-shot wellness...
2021-04-26 8:30 AM EDT
Global Wellness Announces KaleidoMyco Signing The Wolf of Marketing
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2021) - Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) (formerly Redfund Capital Corp.) ("Global" or the "Company") announces KaleidoMyco agreement with digital marketing firm The Wolf of Marketing to launch digital sales platform.KaleidoMyco is about the creation of a strong bond with online consumers and bucking the trend of having to go to stores during the new wave of Covid 19. Building a robust digital sales...
2021-04-14 8:31 AM EDT
Global Wellness Acquires Fast-Growing Mushroom Brand "KaleidoMyco"
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2021) - Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) ("GWS" or the "Company") signs agreement to immediately acquire KaleidoMyco ("KM") world's first company combining hemp extract, adaptogens and myco based ingredients to produce world-class, data-driven, science-based wellness products.The Assets to be acquired by GWS and sold by KM include but are not limited to intellectual...
2021-04-07 9:00 AM EDT
Global Wellness Introduces KaleidoMyco's Trifecta Powder-In-Capsule Combining Functional Mushrooms, Hemp Extract, and Vitamin C
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2021) - Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRF) ("Global" or the "Company") introduces KaleidoMyco's new wellness trifecta powder-in-capsule; combining functional mushrooms, hemp extract and vitamin C. "Bioavailability is critical to the overall impact of supplements entering the bloodstream and having positive affects throughout the body," said Leah Kincaid, founder and...
2021-03-31 8:45 AM EDT
Global Wellness Strategies and EntheoTech Bioscience Sign Letter of Intent; EntheoTech Focused on Functional & Psilocybin Products
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2021) - Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) ("Global" or the "Company") announces it has signed a binding letter of intent ("BLOI") on January 22, 2021 with EntheoTech Bioscience Inc. ("ET") a wellness psilocybin leader based in Kelowna, British Columbia and will have the option to earn up to a 19.9% interest in ET. EntheoTech is a Canadian bioscience company focused...
2021-01-27 8:30 AM EST